Filing status
- Accounts due
- 23 June 2027
- Conf. stmt due
- 6 October 2027
- Last conf. stmt
- 22 September 2026
Fiera Oncology Limited
- Incorporated
- 23 September 2025 (1 year)
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Region
- East of England
- Address
- The Cambridge Partnership The Dorothy Hodgkin BuildingBabraham Research CampusCambridgeCB22 3FH
Officers
Not loaded yet. See them on Companies House
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 23 September 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
Limited Liability Partnership
Reg. no. Oc347034
Group structure 17 companies
Ownership group derived from the Companies House PSC register
Advent Life Sciences GP LLP Right to 75–100% of surplus assets
Advent LS Services Limited Owns 75–100% of shares
Als Growth GP LLP Right to 75–100% of surplus assets
Als Iii Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Als Carry LP Has significant influence or control
Als Iii Carry and Co-Invest LP Part right to 50–75% of surplus assets (as a firm)
Als Iii GP LLP Holds 75–100% of voting rights
Als Iii Member Co Limited Owns 75–100% of shares
Als IV Carry and Co-Invest LP Part right to 75–100% of surplus assets
Als IV Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest GP LLP Holds 25–50% of voting rights
Alsgf Carry and Co-Invest LP Has significant influence or control
Cenentry Biosciences Limited Owns 25–50% of shares
Fiera Oncology Limited This company Owns 25–50% of shares
Pheno Therapeutics Limited Owns 50–75% of shares (as a firm)
Ventus Medical Limited Owns 75–100% of shares
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →